Tesofensine (development code NS-2330) is a synthetic small-molecule triple monoamine reuptake inhibitor. Unlike most compounds in this catalog, it is not a peptide; it is a tropane-derived (8-azabicyclo[3.2.1]octane) compound with the IUPAC name (1R,2R,3S)-3-(3,4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane. It is catalogued under CAS number 195875-84-4, with a molecular formula of C₁₇H₂₃Cl₂NO and a molecular weight of approximately 328.28 g/mol […]
TB-500, as supplied here, is full-length thymosin β4 (Tβ4) — a naturally occurring 43-amino-acid peptide found in nearly all mammalian cell types. It is catalogued under CAS number 77591-33-4, with a molecular formula of C₂₁₂H₃₅₀N₅₆O₇₈S and a molecular weight of approximately 4963.4 g/mol (PubChem CID 16132341). Thymosin β4 is the most abundant member of the […]
SLU-PP-332 is a synthetic small-molecule agonist of the estrogen-related receptors (ERRs). Unlike most compounds in this catalog, it is not a peptide; it is a benzamide-scaffold compound with the IUPAC name 4-hydroxy-N-[(naphthalen-2-ylmethylidene)amino]benzamide. It is catalogued under CAS number 303760-60-3, with a molecular formula of C₁₈H₁₄N₂O₂ and a molecular weight of approximately 290.32 g/mol (PubChem CID […]
Semax is a synthetic heptapeptide with the amino-acid sequence Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP). It is an analogue of the ACTH(4-7) fragment of adrenocorticotropic hormone — the short N-terminal segment associated with the hormone’s nootropic activity — fused with a C-terminal Pro-Gly-Pro tripeptide that confers resistance to enzymatic degradation. The compound is catalogued under CAS number 80714-61-0, with […]
Selank (also designated TP-7) is a synthetic heptapeptide with the amino-acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP). It is a synthetic analogue of tuftsin, a naturally occurring immunomodulatory tetrapeptide (Thr-Lys-Pro-Arg) derived from the heavy chain of human immunoglobulin G; Selank extends that core sequence with a C-terminal Pro-Gly-Pro tripeptide to confer resistance to enzymatic degradation and a longer […]
PT-141 (international nonproprietary name Bremelanotide) is a synthetic cyclic heptapeptide that acts as an agonist at melanocortin receptors. Its sequence is Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH, a cyclic lactam analogue of alpha-melanocyte-stimulating hormone (α-MSH) incorporating the non-standard residues norleucine and D-phenylalanine. The compound is catalogued under CAS number 189691-06-3, with a molecular formula of C₅₀H₆₈N₁₄O₁₀ and a molecular weight […]
Orforglipron (development codes LY3502970 and OWL-833) is a synthetic, orally bioavailable, small-molecule non-peptide agonist of the glucagon-like peptide-1 receptor (GLP-1R). Unlike the injectable peptide GLP-1 receptor agonists, it is a fully synthetic small molecule rationally designed to overcome the poor oral bioavailability and rapid enzymatic degradation of peptide-based agonists. It is catalogued under CAS number […]
NAD+ (nicotinamide adenine dinucleotide) is a fundamental endogenous coenzyme present in all living cells. Unlike most compounds in this catalog, it is neither a synthetic peptide nor a designed small-molecule analogue; it is a naturally occurring dinucleotide composed of two nucleotides — one bearing an adenine base and the other a nicotinamide base — joined […]
IGF-1 LR3 (Long Arginine-3 IGF-1, also written Long R3 IGF-1 or LR3-IGF-1) is a synthetic, lengthened analogue of human insulin-like growth factor 1 (IGF-1). It is an 83-amino-acid single-chain polypeptide, compared with the 70 residues of native IGF-1, and is catalogued under CAS number 143045-27-6, with a molecular formula of C₄₀₀H₆₂₅N₁₁₁O₁₁₅S₉ and a molecular weight […]
The Glow Blend is a combination research product pairing three peptides frequently studied in tissue-repair, skin, and regeneration contexts: GHK-Cu (a copper-binding tripeptide), BPC-157 (a synthetic pentadecapeptide derived from a gastric protein), and TB-500 (supplied here as full-length thymosin β4). The three are combined in a single product because their reported mechanisms in preclinical models […]
